A citation-based method for searching scientific literature

Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova, Gang Liu, Friedrich Feuerhake, Matthew D Ducar, Gerald Illerhaus, Daniel Gusenleitner, Erica A Linden, Heather H Sun, Heather Homer, Miyuki Aono, Geraldine S Pinkus, Azra H Ligon, Keith L Ligon, Judith A Ferry, Gordon J Freeman, Paul van Hummelen, Todd R Golub, Gad Getz, Scott J Rodig, Daphne de Jong, Stefano Monti, Margaret A Shipp. Blood 2016
Times Cited: 305







List of co-cited articles
1052 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma.
Denis Terziev, Barbara Hutter, Barbara Klink, Albrecht Stenzinger, Fabian Stögbauer, Hanno Glimm, Stefan Fröhling, Claudia Wickenhauser, Karin Jordan, Hans-Jürgen Hurtz,[...]. Eur J Haematol 2018
13
46

Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Takashi Sasayama, Satoshi Nakamizo, Masamitsu Nishihara, Atsufumi Kawamura, Hirotomo Tanaka, Katsu Mizukawa, Shigeru Miyake, Masaaki Taniguchi, Kohkichi Hosoda, Eiji Kohmura. Neuro Oncol 2012
86
6

Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.
Alberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, Naïma Habbita, Marta Rossetto, Alice Laurenge, Aurélie Bruno, Anne Jouvet, Marc Polivka, Clovis Adam,[...]. Clin Cancer Res 2012
162
6

Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Sydney Dubois, Pierre-Julien Viailly, Elodie Bohers, Philippe Bertrand, Philippe Ruminy, Vinciane Marchand, Catherine Maingonnat, Sylvain Mareschal, Jean-Michel Picquenot, Dominique Penther,[...]. Clin Cancer Res 2017
62
8


Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
David M Kurtz, Florian Scherer, Michael C Jin, Joanne Soo, Alexander F M Craig, Mohammad Shahrokh Esfahani, Jacob J Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani,[...]. J Clin Oncol 2018
189
5

Chromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma.
H Schwindt, I Vater, M Kreuz, M Montesinos-Rongen, A Brunn, J Richter, S Gesk, O Ammerpohl, O D Wiestler, D Hasenclever,[...]. Leukemia 2009
49
10

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, Ryan M Young, Jonathan M Keller, Dongbo Liu, Ian S Goldlust, Adam Yasgar, Crystal McKnight, Matthew B Boxer,[...]. Proc Natl Acad Sci U S A 2014
262
5

Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.
Eyas M Hattab, Sarah E Martin, Sohaib M Al-Khatib, William J Kupsky, Gail H Vance, Ryan A Stohler, Magdalena Czader, Mousa A Al-Abbadi. Mod Pathol 2010
46
10

Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases.
Jing Liu, Yaming Wang, Yuantao Liu, Zhe Liu, Qu Cui, Nan Ji, Shengjun Sun, Bingxu Wang, Yajie Wang, Xuefei Sun,[...]. Oncol Lett 2017
27
18

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Andrés J M Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote,[...]. Blood 2019
31
16

How we diagnose and treat vitreoretinal lymphoma.
Falko Fend, Andrés J M Ferreri, Sarah E Coupland. Br J Haematol 2016
82
6


PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Sarah Menguy, Martina Prochazkova-Carlotti, Marie Beylot-Barry, Fréderic Saltel, Béatrice Vergier, Jean-Philippe Merlio, Anne Pham-Ledard. Am J Surg Pathol 2018
30
16

The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
David D W Twa, Anja Mottok, Kerry J Savage, Christian Steidl. Blood Rev 2018
18
27

Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Anja Mottok, Stacy S Hung, Elizabeth A Chavez, Bruce Woolcock, Adèle Telenius, Lauren C Chong, Barbara Meissner, Hisae Nakamura, Christopher Rushton, Elena Viganò,[...]. Blood 2019
52
9

Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas.
Lauren C Chong, David D W Twa, Anja Mottok, Susana Ben-Neriah, Bruce W Woolcock, Yongjun Zhao, Kerry J Savage, Marco A Marra, David W Scott, Randy D Gascoyne,[...]. Blood 2016
40
12

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
Stefano Monti, Kerry J Savage, Jeffery L Kutok, Friedrich Feuerhake, Paul Kurtin, Martin Mihm, Bingyan Wu, Laura Pasqualucci, Donna Neuberg, Ricardo C T Aguiar,[...]. Blood 2005
588
5

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
Margaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, Christine J Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, Anas Younes, Michelle Fanale, Armando Santoro,[...]. J Clin Oncol 2018
192
5

The tumour microenvironment in B cell lymphomas.
David W Scott, Randy D Gascoyne. Nat Rev Cancer 2014
311
5

T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
Suvi-Katri Leivonen, Marjukka Pollari, Oscar Brück, Teijo Pellinen, Matias Autio, Marja-Liisa Karjalainen-Lindsberg, Susanna Mannisto, Pirkko-Liisa Kellokumpu-Lehtinen, Olli Kallioniemi, Satu Mustjoki,[...]. Haematologica 2019
26
19

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
Georg Lenz, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, George W Wright, Sandeep S Dave, Hong Zhao, Weihong Xu, Andreas Rosenwald,[...]. Science 2008
624
5

Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
L Fischer, E Thiel, H-A Klasen, J Birkmann, K Jahnke, P Martus, A Korfel. Ann Oncol 2006
99
5

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Magdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler, Federica Cavallo, Jie Jin, Maurizio Martelli, Douglas Stewart, Umberto Vitolo, Francesco Zaja, Qingyuan Zhang,[...]. Blood 2019
60
8

Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL.
Kerry J Savage, Graham W Slack, Anja Mottok, Laurie H Sehn, Diego Villa, Roopesh Kansara, Robert Kridel, Christian Steidl, Daisuke Ennishi, King L Tan,[...]. Blood 2016
113
5

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
Robert Kridel, David Telio, Diego Villa, Laurie H Sehn, Alina S Gerrie, Tamara Shenkier, Richard Klasa, Graham W Slack, King Tan, Randy D Gascoyne,[...]. Br J Haematol 2017
45
11

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group.
E Zucca, A Conconi, T I Mughal, A H Sarris, J F Seymour, U Vitolo, R Klasa, M Ozsahin, G M Mead, M A Gianni,[...]. J Clin Oncol 2003
283
5

Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Melissa Alame, Marion Pirel, Valérie Costes-Martineau, Luc Bauchet, Michel Fabbro, Alicia Tourneret, Laura De Oliveira, Luc Durand, Pascal Roger, Samia Gonzalez,[...]. Virchows Arch 2020
16
31

Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma.
Zhi-Zhang Yang, Hyo Jin Kim, Jose C Villasboas, Ya-Ping Chen, Tammy Price-Troska, Shahrzad Jalali, Mara Wilson, Anne J Novak, Stephen M Ansell. Oncotarget 2017
96
5

Combined modality therapy for primary CNS lymphoma.
L M DeAngelis, J Yahalom, H T Thaler, U Kher. J Clin Oncol 1992
432
5

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
Lisa M DeAngelis, Wendy Seiferheld, S Clifford Schold, Barbara Fisher, Christopher J Schultz. J Clin Oncol 2002
484
5

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Frederick L Locke, Armin Ghobadi, Caron A Jacobson, David B Miklos, Lazaros J Lekakis, Olalekan O Oluwole, Yi Lin, Ira Braunschweig, Brian T Hill, John M Timmerman,[...]. Lancet Oncol 2019
949
5

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
Jon Glass, Minhee Won, Christopher J Schultz, Daniel Brat, Nancy L Bartlett, John H Suh, Maria Werner-Wasik, Barbara Jean Fisher, Marcia K Liepman, Mark Augspurger,[...]. J Clin Oncol 2016
76
6

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Anas Younes, Joshua Brody, Cecilia Carpio, Armando Lopez-Guillermo, Dina Ben-Yehuda, Burhan Ferhanoglu, Arnon Nagler, Muhit Ozcan, Irit Avivi, Francesc Bosch,[...]. Lancet Haematol 2019
102
5

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Zijun Y Xu-Monette, Jianfeng Zhou, Ken H Young. Blood 2018
215
5

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation.
Matthew J Frigault, Philippe Armand, Robert A Redd, Erin Jeter, Reid W Merryman, Kimberly C Coleman, Alex F Herrera, Parastoo Dahi, Yago Nieto, Ann S LaCasce,[...]. Blood Adv 2020
28
17

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Wei Ding, Betsy R LaPlant, Timothy G Call, Sameer A Parikh, Jose F Leis, Rong He, Tait D Shanafelt, Sutapa Sinha, Jennifer Le-Rademacher, Andrew L Feldman,[...]. Blood 2017
242
5

Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
Wei Jian Tan, Mona Meng Wang, Paola Ricciardi-Castagnoli, Tiffany Tang, Soon Phaik Chee, Tong Seng Lim, Anita Sook Yee Chan. Blood 2019
13
38

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.
Keisuke Kataoka, Hiroaki Miyoshi, Seiji Sakata, Akito Dobashi, Lucile Couronné, Yasunori Kogure, Yasuharu Sato, Kenji Nishida, Yuka Gion, Yuichi Shiraishi,[...]. Leukemia 2019
67
7

Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
Maxime Fontanilles, Florent Marguet, Élodie Bohers, Pierre-Julien Viailly, Sydney Dubois, Philippe Bertrand, Vincent Camus, Sylvain Mareschal, Philippe Ruminy, Catherine Maingonnat,[...]. Oncotarget 2017
56
8

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
Florian Scherer, David M Kurtz, Aaron M Newman, Henning Stehr, Alexander F M Craig, Mohammad Shahrokh Esfahani, Alexander F Lovejoy, Jacob J Chabon, Daniel M Klass, Chih Long Liu,[...]. Sci Transl Med 2016
252
5

Genetic heterogeneity of diffuse large B-cell lymphoma.
Jenny Zhang, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, William Choi, Wing Yan Au, Gopesh Srivastava,[...]. Proc Natl Acad Sci U S A 2013
404
5

The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma.
Yuko Miyasato, Yasuo Takashima, Hiroto Takeya, Hiromu Yano, Azusa Hayano, Takenobu Nakagawa, Keishi Makino, Motohiro Takeya, Ryuya Yamanaka, Yoshihiro Komohara. J Clin Exp Hematop 2018
30
16

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.
Chang Ohk Sung, Sang Cheol Kim, Sivasundaram Karnan, Kennosuke Karube, Hyung Jin Shin, Do-Hyun Nam, Yeon-Lim Suh, Seok-Hyung Kim, Ji Yeon Kim, Seok Jin Kim,[...]. Blood 2011
67
7

Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
Martina Deckert, Manuel Montesinos-Rongen, Anna Brunn, Reiner Siebert. Acta Neuropathol 2014
47
10

APRIL and BAFF: novel biomarkers for central nervous system lymphoma.
Matthias Mulazzani, Marion Huber, Sabine Borchard, Sigrid Langer, Barbara Angele, Elisabeth Schuh, Edgar Meinl, Martin Dreyling, Tobias Birnbaum, Andreas Straube,[...]. J Hematol Oncol 2019
18
27

Low-dose lenalidomide maintenance after induction therapy in older patients with primary central nervous system lymphoma.
Khoan Vu, Gabriel Mannis, Jimmy Hwang, Huimin Geng, James L Rubenstein. Br J Haematol 2019
19
26

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
Lisa M Rimsza, Robin A Roberts, Thomas P Miller, Joseph M Unger, Michael LeBlanc, Rita M Braziel, Dennis D Weisenberger, Wing C Chan, H Konrad Muller-Hermelink, Elaine S Jaffe,[...]. Blood 2004
251
5

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?
Marcel Nijland, Rianne N Veenstra, Lydia Visser, Chuanhui Xu, Kushi Kushekhar, Gustaaf W van Imhoff, Philip M Kluin, Anke van den Berg, Arjan Diepstra. Oncoimmunology 2017
68
7

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos,[...]. Blood 2019
160
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.